Article
BRCA1 loses the ring but lords over resistance.
The Journal of clinical investigation - 1 Aug 2016
Powell Simon N
Abstract excerpt
Germline breast cancer 1 (BRCA1) variants are associated with a high risk of breast and ovarian cancers. Many BRCA1-mediated cancers are initially responsive to platinum-based therapy; however, resistance commonly develops. The BRCA1185delAG mutation is common in the Ashkenazi Jewish population and has been thought to result in loss of function due to the introduction of a stop codon in the 5' region of the BRCA1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
